A detailed history of Bokf, Na transactions in Catalent, Inc. stock. As of the latest transaction made, Bokf, Na holds 1 shares of CTLT stock, worth $63. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1
Holding current value
$63
% of portfolio
0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$56.16 - $60.96 $56 - $60
1 New
1 $0
Q1 2023

May 11, 2023

BUY
$45.44 - $74.26 $11,132 - $18,193
245 New
245 $16,000
Q2 2022

Aug 11, 2022

SELL
$87.2 - $114.05 $155,041 - $202,780
-1,778 Reduced 48.07%
1,921 $206,000
Q1 2022

May 13, 2022

BUY
$94.19 - $124.49 $156,637 - $207,026
1,663 Added 81.68%
3,699 $410,000
Q4 2021

Mar 11, 2022

SELL
$119.57 - $139.07 $11,359 - $13,211
-95 Reduced 4.46%
2,036 $261,000
Q3 2021

Nov 10, 2021

SELL
$109.17 - $142.35 $545 - $711
-5 Reduced 0.23%
2,131 $284,000
Q1 2021

Apr 21, 2021

BUY
$101.51 - $125.27 $216,825 - $267,576
2,136 New
2,136 $225,000

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11.4B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Bokf, Na Portfolio

Follow Bokf, Na and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bokf, Na, based on Form 13F filings with the SEC.

News

Stay updated on Bokf, Na with notifications on news.